Taiwan · Delayed Price · Currency is TWD TSH Biopharm Corporation Statistics
Total Valuation
TPEX:8432 has a market cap or net worth of TWD 1.91 billion. The enterprise value is 1.12 billion.
| Market Cap | 1.91B |
| Enterprise Value | 1.12B |
Important Dates
The next estimated earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | Jun 12, 2026 |
Share Statistics
TPEX:8432 has 38.40 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 38.40M |
| Shares Outstanding | 38.40M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 2.15% |
| Owned by Institutions (%) | 0.72% |
| Float | 14.69M |
Valuation Ratios
The trailing PE ratio is 11.43.
| PE Ratio | 11.43 |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | 6.85 |
| P/OCF Ratio | 6.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.02, with an EV/FCF ratio of 4.04.
| EV / Earnings | 6.72 |
| EV / Sales | 0.80 |
| EV / EBITDA | 4.02 |
| EV / EBIT | 4.44 |
| EV / FCF | 4.04 |
Financial Position
The company has a current ratio of 4.33, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.33 |
| Quick Ratio | 3.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.05 |
| Interest Coverage | 314.01 |
Financial Efficiency
Return on equity (ROE) is 13.44% and return on invested capital (ROIC) is 30.74%.
| Return on Equity (ROE) | 13.44% |
| Return on Assets (ROA) | 8.16% |
| Return on Invested Capital (ROIC) | 30.74% |
| Return on Capital Employed (ROCE) | 15.04% |
| Weighted Average Cost of Capital (WACC) | 5.94% |
| Revenue Per Employee | 18.38M |
| Profits Per Employee | 2.20M |
| Employee Count | 76 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 4.33 |
Taxes
In the past 12 months, TPEX:8432 has paid 51.63 million in taxes.
| Income Tax | 51.63M |
| Effective Tax Rate | 19.09% |
Stock Price Statistics
The stock price has increased by +4.49% in the last 52 weeks. The beta is 0.31, so TPEX:8432's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +4.49% |
| 50-Day Moving Average | 50.67 |
| 200-Day Moving Average | 52.87 |
| Relative Strength Index (RSI) | 46.05 |
| Average Volume (20 Days) | 30,861 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:8432 had revenue of TWD 1.40 billion and earned 167.21 million in profits. Earnings per share was 4.35.
| Revenue | 1.40B |
| Gross Profit | 721.55M |
| Operating Income | 253.09M |
| Pretax Income | 270.41M |
| Net Income | 167.21M |
| EBITDA | 266.58M |
| EBIT | 253.09M |
| Earnings Per Share (EPS) | 4.35 |
Balance Sheet
The company has 1.06 billion in cash and 15.11 million in debt, with a net cash position of 1.05 billion or 27.25 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 15.11M |
| Net Cash | 1.05B |
| Net Cash Per Share | 27.25 |
| Equity (Book Value) | 1.68B |
| Book Value Per Share | 36.85 |
| Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was 280.00 million and capital expenditures -1.48 million, giving a free cash flow of 278.52 million.
| Operating Cash Flow | 280.00M |
| Capital Expenditures | -1.48M |
| Depreciation & Amortization | 13.49M |
| Net Borrowing | -12.57M |
| Free Cash Flow | 278.52M |
| FCF Per Share | 7.25 |
Margins
Gross margin is 51.66%, with operating and profit margins of 18.12% and 11.97%.
| Gross Margin | 51.66% |
| Operating Margin | 18.12% |
| Pretax Margin | 19.36% |
| Profit Margin | 11.97% |
| EBITDA Margin | 19.09% |
| EBIT Margin | 18.12% |
| FCF Margin | 19.94% |
Dividends & Yields
This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 5.16%.
| Dividend Per Share | 2.61 |
| Dividend Yield | 5.16% |
| Dividend Growth (YoY) | 23.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 48.68% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 5.11% |
| Earnings Yield | 8.76% |
| FCF Yield | 14.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
TPEX:8432 has an Altman Z-Score of 5.63 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.63 |
| Piotroski F-Score | 6 |